https://ansm.sante.fr/tableau-acces-derogatoire/zanidatamab 2025 false false false France French infusions, intravenous zanidatamab drug information summary of product characteristics package leaflet adult biliary tract neoplasms HER2 positive biliary tract cancer HER2/Neu Expression by Immunohistochemistry 3+ zanidatamab Locally Advanced Bile Duct Carcinoma Metastatic Bile Duct Carcinoma Unresectable Bile Duct Carcinoma guidelines for drug use
--- https://www.has-sante.fr/jcms/p_3563099/fr/ziihera-zanidatamab-cancer-des-voies-biliaires 2024 false false false France treatment outcome insurance, health, reimbursement HER2/Neu Expression by Immunohistochemistry 3+ adult guidelines for drug use infusions, intravenous zanidatamab evaluation of the transparency committee biliary tract cancer zanidatamab biliary tract neoplasms